Drug intelligence / Profile preview

Yunpingfang Jiawei granules

Development stage
Unknown
Lead developer
First Affiliated Hospital of Henan University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Yunpingfang Jiawei granules is a Traditional Chinese Medicine (TCM) hospital preparation developed by the First Affiliated Hospital of Henan University of Chinese Medicine. It is specifically formulated to treat vertigo (dizziness) associated with conditions such as Meniere's disease, vestibular migraine, and cervical spondylosis of the vertebral artery type. The formulation is based on the classic Banxia Baizhu Tianma Tang, modified with additional herbs to enhance its efficacy in extinguishing internal wind, resolving phlegm, and tonifying the spleen. Pharmacological studies indicate that the granules work by improving blood flow velocity in the vertebral and basilar arteries, reducing blood viscosity, and potentially regulating endolymphatic pressure in the inner ear. It is commonly used in clinical practice in China for patients presenting with the Wind-Phlegm Up-disturbing pattern of vertigo.

Brand names
Yunpingfang Jiawei granules
Other names
晕平方加味颗粒Yunpingfang Jiawei KenliYunpingfang

Beyond the preview

Go deeper on Yunpingfang Jiawei granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunpingfang Jiawei granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call